In a report released yesterday, Anderson Schock from B. Riley Securities reiterated a Buy rating on Inogen, with a price target of $14.00. The company’s shares closed yesterday at $6.36.

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

The report identifies the key global players in environmental & sustainability (E&S) consulting revenue for FY 2024. LEEDS, GB / ACCESS Newswire / January 15, 2026 / Antea Group UK is proud to be rank ...

GOLETA, Calif. - Medical technology company Inogen, Inc. (NASDAQ:INGN) announced Wednesday the launch of its new Aurora CPAP masks, marking the company’s entry into the sleep apnea market. The company ...

Inogen Inc. research and ratings by Barron's. View INGN revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.

GOLETA, Calif. (AP) — GOLETA, Calif. (AP) — Inogen Inc. (INGN) on Wednesday reported a loss of $5.3 million in its third quarter. On a per-share basis, the Goleta, California-based company said it had ...

Income tax impact of adjustments represents the tax impact related to the non-GAAP adjustments listed above and reflects an effective tax rate of 0% for 2025 and 2024. The articles, information, and ...

Welcome to Inogen's Second Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded today, August 7, 2025. I would now like to turn the call over ...

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced management will participate in the 24th Annual ...